Show simple item record

dc.contributor.authorMagnussen, Helgo
dc.contributor.authorLucas, Sarah J
dc.contributor.authorLapperre, Therese S
dc.contributor.authorQuint, Jennifer K
dc.contributor.authorDandurand, Ronald J.
dc.contributor.authorRoche, Nicolas
dc.contributor.authorPapi, Alberto
dc.contributor.authorPrice, David
dc.contributor.authorMiravitlles, Marc
dc.contributor.authorRespiratory Effectiveness Group (REG)
dc.date.accessioned2021-02-01T11:12:01Z
dc.date.available2021-02-01T11:12:01Z
dc.date.issued2021-01-21
dc.identifier.citationMagnussen , H , Lucas , S J , Lapperre , T S , Quint , J K , Dandurand , R J , Roche , N , Papi , A , Price , D , Miravitlles , M & Respiratory Effectiveness Group (REG) 2021 , ' Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life : Observational comparative effectiveness study ' , Respiratory Research , vol. 22 , 25 . https://doi.org/10.1186/s12931-021-01615-0en
dc.identifier.issn1465-9921
dc.identifier.otherPURE: 185425894
dc.identifier.otherPURE UUID: 56139a9a-f53d-4317-9a24-a88128750eb1
dc.identifier.otherScopus: 85099858586
dc.identifier.otherPubMed: 33478491
dc.identifier.otherWOS: 000612880800001
dc.identifier.urihttps://hdl.handle.net/2164/15758
dc.descriptionFUNDING The study was funded by a grant from Boehringer Ingelheim. ACKNOWLEDGMENTS The study was designed and conducted by the Respiratory Effectiveness Group (REG; www.regresearchnetwork.org; Ely, UK) and data was delivered by Optimum Patient Care (OPC; www.optimumpatientcare.org) with support from Derek Skinner.en
dc.format.extent14
dc.language.isoeng
dc.relation.ispartofRespiratory Researchen
dc.rights© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectCOPDen
dc.subjectInhaled corticosteroidsen
dc.subjectWithdrawalen
dc.subjectreal lifeen
dc.subjecteffectivenessen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectAdministration, Inhalationen
dc.subjectMaleen
dc.subjectTreatment Outcomeen
dc.subjectUnited Kingdom/epidemiologyen
dc.subjectSafety-Based Drug Withdrawals/trendsen
dc.subjectPulmonary Disease, Chronic Obstructive/diagnosisen
dc.subjectAged, 80 and overen
dc.subjectFemaleen
dc.subjectAdrenal Cortex Hormones/administration & dosageen
dc.subjectAgeden
dc.subjectBronchodilator Agents/administration & dosageen
dc.subjectReal lifeen
dc.subjectEffectivenessen
dc.subjectR Medicineen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleWithdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life : Observational comparative effectiveness studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12931-021-01615-0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record